Published in Neurotoxicology on May 05, 2007
Isoliquiritigenin is a novel NMDA receptor antagonist in kampo medicine yokukansan. Cell Mol Neurobiol (2011) 0.95
Researching glutamate - induced cytotoxicity in different cell lines: a comparative/collective analysis/study. Front Cell Neurosci (2015) 0.93
The NMDA receptor functions independently and as an LRP1 co-receptor to promote Schwann cell survival and migration. J Cell Sci (2015) 0.82
Mitochondria and NMDA receptor-dependent toxicity of berberine sensitizes neurons to glutamate and rotenone injury. PLoS One (2014) 0.81
Yokukansan, a kampo medicine, protects PC12 cells from glutamate-induced death by augmenting gene expression of cystine/glutamate antiporter system Xc-. PLoS One (2014) 0.80
Interaction between calpain-1 and HSP90: new insights into the regulation of localization and activity of the protease. PLoS One (2015) 0.80
Effects of Low Amyloid-β (Aβ) Concentration on Aβ1-42 Oligomers Binding and GluN2B Membrane Expression. J Alzheimers Dis (2015) 0.75
Cellular Pharmacological Effects of the Traditional Japanese Kampo Medicine Yokukansan on Brain Cells. Front Pharmacol (2017) 0.75
Molecular diversity of rumen methanogens from sheep in Western Australia. Appl Environ Microbiol (2004) 1.82
Opioids: cellular mechanisms of tolerance and physical dependence. Curr Opin Pharmacol (2005) 1.82
Opioid agonists have different efficacy profiles for G protein activation, rapid desensitization, and endocytosis of mu-opioid receptors. J Biol Chem (2003) 1.78
Hand-held dynamometry correlation with the gold standard isokinetic dynamometry: a systematic review. PM R (2011) 1.58
Angiotensin-converting enzyme inhibitor limits pulse-wave velocity and aortic calcification in a rat model of cystic renal disease. Am J Physiol Renal Physiol (2011) 1.54
Characterization of GATA3 mutations in the hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome. J Biol Chem (2004) 1.47
Differential contribution of afferent and central pathways to the development of baroreflex dysfunction in chronic kidney disease. Hypertension (2013) 1.43
Capsaicin activation of glutamatergic synaptic transmission in the rat locus coeruleus in vitro. J Physiol (2002) 1.29
Independent effects of systemic and peritoneal inflammation on peritoneal dialysis survival. J Am Soc Nephrol (2013) 1.18
Opioid tolerance in periaqueductal gray neurons isolated from mice chronically treated with morphine. Br J Pharmacol (2005) 1.16
Gingerols: a novel class of vanilloid receptor (VR1) agonists. Br J Pharmacol (2002) 1.11
Anandamide is a partial agonist at native vanilloid receptors in acutely isolated mouse trigeminal sensory neurons. Br J Pharmacol (2002) 1.11
Upregulation of angiotensin AT1 receptor and intracellular kinase gene expression in hypertensive rats. Clin Exp Pharmacol Physiol (2006) 1.03
The role of opioid receptor phosphorylation and trafficking in adaptations to persistent opioid treatment. Neurosignals (2005) 1.01
Inhibition of human recombinant T-type calcium channels by the endocannabinoid N-arachidonoyl dopamine. Br J Pharmacol (2009) 1.01
Inhibition of recombinant human T-type calcium channels by Delta9-tetrahydrocannabinol and cannabidiol. J Biol Chem (2008) 1.00
Use of HLA typing in diagnosing celiac disease in patients with type 1 diabetes. Diabetes Care (2005) 0.98
Real-time characterization of cannabinoid receptor 1 (CB1 ) allosteric modulators reveals novel mechanism of action. Br J Pharmacol (2013) 0.97
Aortic stiffness is associated with vascular calcification and remodeling in a chronic kidney disease rat model. Am J Physiol Renal Physiol (2011) 0.96
Prostaglandin E(2) inhibits calcium current in two sub-populations of acutely isolated mouse trigeminal sensory neurons. J Physiol (2002) 0.96
Development and validation of a real-time PCR method to quantify rumen protozoa and examination of variability between entodinium populations in sheep offered a hay-based diet. Appl Environ Microbiol (2006) 0.96
A novel mutation causing nephronophthisis in the Lewis polycystic kidney rat localises to a conserved RCC1 domain in Nek8. BMC Genomics (2012) 0.96
Unravelling the pathophysiology of complex regional pain syndrome: focus on sympathetically maintained pain. Clin Exp Pharmacol Physiol (2008) 0.93
ErbB3 downregulation enhances luminal breast tumor response to antiestrogens. J Clin Invest (2013) 0.92
Prospective study of effect of androgens on serum inflammatory markers in men. Arterioscler Thromb Vasc Biol (2002) 0.91
Reponses of sheep to a vaccination of entodinial or mixed rumen protozoal antigens to reduce rumen protozoal numbers. Br J Nutr (2007) 0.91
Expression of the noradrenaline transporter and phenylethanolamine N-methyltransferase in normal human adrenal gland and phaeochromocytoma. Cell Tissue Res (2005) 0.90
A continuous, fluorescence-based assay of μ-opioid receptor activation in AtT-20 cells. J Biomol Screen (2012) 0.89
TRPV1 antagonists as a potential treatment for hyperalgesia. Recent Pat CNS Drug Discov (2006) 0.87
Flow cytometry in the study of mitochondrial respiratory chain disorders. Mitochondrion (2002) 0.86
Sumatriptan inhibits synaptic transmission in the rat midbrain periaqueductal grey. Mol Pain (2008) 0.86
Temporal relationship between renal cyst development, hypertension and cardiac hypertrophy in a new rat model of autosomal recessive polycystic kidney disease. Kidney Blood Press Res (2007) 0.86
Systemic decreases in cutaneous innervation after burn injury. J Invest Dermatol (2010) 0.85
The synthesis and pharmacological evaluation of adamantane-derived indoles: cannabimimetic drugs of abuse. ACS Chem Neurosci (2013) 0.84
Development of a non-targeted metabolomics method to investigate urine in a rat model of polycystic kidney disease. Nephrology (Carlton) (2012) 0.84
Decreased mu-opioid receptor signalling and a reduction in calcium current density in sensory neurons from chronically morphine-treated mice. Br J Pharmacol (2006) 0.84
Early cyst growth is associated with the increased nuclear expression of cyclin D1/Rb protein in an autosomal-recessive polycystic kidney disease rat model. Nephron Exp Nephrol (2010) 0.84
Changes in cutaneous innervation in patients with chronic pain after burns. Burns (2011) 0.84
Cardiovascular autonomic dysfunction in a novel rodent model of polycystic kidney disease. Auton Neurosci (2009) 0.83
The norepinephrine transporter and pheochromocytoma. Ann N Y Acad Sci (2006) 0.82
A preliminary investigation of the reinnervation and return of sensory function in burn patients treated with INTEGRA®. Burns (2011) 0.81
Pharmacological characterization of a recombinant, fluorescent somatostatin receptor agonist. Bioconjug Chem (2011) 0.81
Usefulness of [18F]-DA and [18F]-DOPA for PET imaging in a mouse model of pheochromocytoma. Nucl Med Biol (2011) 0.81
Methanandamide activation of a novel current in mouse trigeminal ganglion sensory neurons in vitro. Neuropharmacology (2007) 0.81
Cellular signalling of non-synonymous single-nucleotide polymorphisms of the human μ-opioid receptor (OPRM1). Br J Pharmacol (2014) 0.81
A real-time, fluorescence-based assay for measuring μ-opioid receptor modulation of adenylyl cyclase activity in Chinese hamster ovary cells. J Biomol Screen (2013) 0.80
Neuropeptide Y expression in phaeochromocytomas: relative absence in tumours from patients with von Hippel-Lindau syndrome. J Endocrinol (2007) 0.80
Functional expression of muscarinic and purinoceptors in the urinary bladder of male and female rats and guinea pigs. J Smooth Muscle Res (2010) 0.80
Unique levels of expression of N-methyl-D-aspartate receptor subunits and neuronal nitric oxide synthase in the rostral ventrolateral medulla of the spontaneously hypertensive rat. Brain Res Mol Brain Res (2004) 0.80
Inhibition of human recombinant T-type calcium channels by N-arachidonoyl 5-HT. Br J Pharmacol (2012) 0.79
UK Renal Registry 12th Annual Report (December 2009): chapter 11: blood pressure profile of prevalent patients receiving dialysis in the UK in 2008: national and centre-specific analyses. Nephron Clin Pract (2010) 0.79
Tyrosine hydroxylase gene expression in ventrolateral medulla oblongata of WKY and SHR: a quantitative real-time polymerase chain reaction study. Auton Neurosci (2002) 0.79
UK Renal Registry 11th Annual Report (December 2008): Chapter 9 Haemoglobin, ferritin and erythropoietin amongst patients receiving dialysis in the UK in 2007: national and centre-specific analyses. Nephron Clin Pract (2009) 0.78
Adaptation of a mitochondrial complex III assay for automation: examination of reproducibility and precision. Clin Chem (2003) 0.78
Cyclic sulfamidates as vehicles for the synthesis of substituted lactams. Org Lett (2004) 0.78
Buprenorphine signalling is compromised at the N40D polymorphism of the human μ opioid receptor in vitro. Br J Pharmacol (2014) 0.78
The results of an experimental indoor hydroponic Cannabis growing study, using the 'Screen of Green' (ScrOG) method-Yield, tetrahydrocannabinol (THC) and DNA analysis. Forensic Sci Int (2010) 0.78
Temporal development of baroreceptor dysfunction in a rodent model of chronic kidney disease. Clin Exp Pharmacol Physiol (2013) 0.78
Distinct subpopulations of cyclic guanosine monophosphate (cGMP) and neuronal nitric oxide synthase (nNOS) containing sympathetic preganglionic neurons in spontaneously hypertensive and Wistar-Kyoto rats. J Comp Neurol (2006) 0.78
Reactivity of cyclic sulfamidates towards phosphonate-stabilised enolates: synthesis and applications of alpha-phosphono lactams. Org Biomol Chem (2007) 0.77
Effects of vasopressin on isolated rat adrenal chromaffin cells. Regul Pept (2002) 0.77
Measures of care in adult renal transplant recipients in the United Kingdom (chapter 11). Nephrol Dial Transplant (2007) 0.77
Comparative studies of PC12 and mouse pheochromocytoma-derived rodent cell lines as models for the study of neuroendocrine systems. In Vitro Cell Dev Biol Anim (2005) 0.77
Functional effects of genetic polymorphism in inflammatory genes in subjective memory complainers. Neurobiol Aging (2010) 0.77
Convulsant actions of calycanthine. Toxicol Appl Pharmacol (2003) 0.77
Immunohistochemical assessment of cyclic guanosine monophosphate (cGMP) and soluble guanylate cyclase (sGC) within the rostral ventrolateral medulla. J Biomed Sci (2008) 0.77
Targeting somatostatin receptors using in situ-bioconjugated fluorescent nanoparticles. Nanomedicine (Lond) (2012) 0.77
The effect of losartan on differential reflex control of sympathetic nerve activity in chronic kidney disease. J Hypertens (2015) 0.77
Heterogeneous distribution of basal cyclic guanosine monophosphate within distinct neuronal populations in the hypothalamic paraventricular nucleus. Am J Physiol Regul Integr Comp Physiol (2008) 0.77
Abnormal central control underlies impaired baroreflex control of heart rate and sympathetic nerve activity in female Lewis polycystic kidney rats. J Hypertens (2015) 0.76
UK Renal Registry 11th Annual Report (December 2008): Chapter 11 Blood pressure profile of prevalent patients receiving dialysis in the UK in 2007: national and centre-specific analyses. Nephron Clin Pract (2009) 0.76
Up-regulation of cutaneous α1 -adrenoceptors in complex regional pain syndrome type I. Pain Med (2014) 0.76
Chronic treatment with tempol does not significantly ameliorate renal tissue hypoxia or disease progression in a rodent model of polycystic kidney disease. Clin Exp Pharmacol Physiol (2012) 0.76
Protective cardiorenal effects of spironolactone in a rodent model of polycystic kidney disease. Clin Exp Pharmacol Physiol (2015) 0.76
BK channels, baroreflex sensitivity and genetic markers. J Hypertens (2002) 0.75
A6V polymorphism of the human μ-opioid receptor decreases signalling of morphine and endogenous opioids in vitro. Br J Pharmacol (2015) 0.75
Differential expression of the NMDA NR2B receptor subunit in motoneuron populations susceptible and resistant to amyotrophic lateral sclerosis. Neurosci Lett (2006) 0.75
UK Renal Registry 19th Annual Report: Chapter 7 Haemoglobin, Ferritin and Erythropoietin amongst UK Adult Dialysis Patients in 2015: National and Centre-specific Analyses. Nephron (2017) 0.75
UK Renal Registry 18th Annual Report: Chapter 8 Haemoglobin, Ferritin and Erythropoietin amongst UK Adult Dialysis Patients in 2014: National and Centre-specific Analyses. Nephron (2016) 0.75
Fluorescence-based, high-throughput assays for μ-opioid receptor activation using a membrane potential-sensitive dye. Methods Mol Biol (2015) 0.75
Reactivity of cyclic sulfamidates towards sulfur-stabilised enolates. Stereocontrolled synthesis of functionalised lactams. Org Biomol Chem (2006) 0.75
Long-Term Angiotensin II Receptor Blockade Limits Hypertension, Aortic Dysfunction, and Structural Remodeling in a Rat Model of Chronic Kidney Disease. J Vasc Res (2016) 0.75
Chapter 7 Adequacy of haemodialysis in UK adult patients in 2010: national and centre-specific analyses. Nephron Clin Pract (2012) 0.75
UK Renal Registry 17th Annual Report: Chapter 7 Haemoglobin, Ferritin and Erythropoietin amongst UK Adult Dialysis Patients in 2013: National and Centre-specific Analyses. Nephron (2015) 0.75
Increased arterial stiffness does not respond to renal denervation in an animal model of secondary hypertension. Conf Proc IEEE Eng Med Biol Soc (2017) 0.75
Development of Bright and Biocompatible Nanoruby and its Application to Background-free Time-gated Imaging of G-protein Coupled Receptors. ACS Appl Mater Interfaces (2017) 0.75
Effects of meloxicam and phenylbutazone on renal responses to furosemide, dobutamine, and exercise in horses. Am J Vet Res (2014) 0.75
Factors which may influence cardiovascular disease in dialysis and transplant patients--blood pressure (chapter 10). Nephrol Dial Transplant (2007) 0.75